《广州医药》
点击关注官方服务号追踪稿件状态

【重要服务提醒】《广州医药》杂志服务号已上线稿件查询功能

各位作者、审稿专家:
本刊官方微信服务号新增稿件状态查询服务,无需反复登录投稿系统,微信即可随时查看审稿进度、修回通知、录用结果,稿件更新实时推送提醒,同步接收期刊征稿、学术资讯。

操作方式

微信搜索关注广州医药杂志服务号 → 点击菜单栏「绑定账号」→ 输入投稿邮箱完成账号关联;请关闭微信消息免打扰,避免遗漏稿件通知。

《广州医药》编辑部

广州医药杂志服务号
论著

血浆置换治疗抗MDA5阳性皮肌炎伴肺间质纤维化临床疗效及安全性分析

Clinical efficacy and safety analysis of plasmapheresis for anti-MDA 5 positive dermatomositis with lung interstitial fibrosis

:1166-1171
 
目的 探讨血浆置换联合泼尼松(PDN)联合环磷酰胺(CTX)治疗抗黑色素瘤分化相关基因5(MDA5)抗体阳性皮肌炎(DM)伴肺间质纤维化(ILD)患者疗效及安全性。方法 回顾性分析2014年6月—2023年6月普洱市人民医院诊断的MDA5阳性DM伴ILD患者40例,其中治疗组20例,采用血浆置换联合PDN 1 mg/kg每日1次口服,4周后减量,每周减总量10%,CTX 1 g每月1次静脉滴注,共6次治疗;另20例设为对照组,采用PDN 1 mg/kg每日1次口服,4周后减量,每周减总量10%,CTX 1 g每月1次静脉滴注,共6次治疗,分别于治疗后3月、6月检测一氧化碳弥散量(DLCO)、第1秒用力呼气量(FEV1),血清铁蛋白(SF)、C-反应蛋白(CRP)、涎液化糖链抗原(KL-6)、MDA5转阴率行疗效评估。结果 在治疗3个月和6个月时,两组患者的DLCO、FEV1、SF、CRP、KL-6、MDA5转阴率等指标的完全缓解率不一致。其中,3个月时,治疗组上述指标的完全缓解率依次为95%、85%、90%、90%、90%、85%,对照组依次为15%、20%、20%、15%、0%、0%。两组患者在治疗3个月的DLCO、FEV1、SF、CRP、KL-6水平和MDA5转阴数均有所不同。其中治疗组的DLCO、KL-6、CRP水平均较对照组降低(P<0.01),治疗组FEV1水平较对照组升高(P<0.01),治疗组SF水平较对照组降低(P<0.05),两组治疗6个月时,治疗组上述指标缓解率依次为95%、85%、90%、90%、90%、85%,对照组依次为20%、25%、20%、20%、20%、5%。两组患者在DLCO、FEV1、SF、CRP、KL-6水平以及MDA5转阴数和死亡例数方面比较差异均有统计学意义,其中治疗组的DLCO、KL-6和CRP水平均较对照组降低(P<0.01),治疗组FEV1水平较对照组升高(P<0.01),SF水平治疗组较对照组降低(P<0.05)。结论 在MDA5抗体阳性DM伴ILD患者治疗中,给予血浆置换联合PDN、CTX治疗,可以提高疗效,降低病死率。
Objective To explore the effect of plasmapheresis combined with prednisone(PDN)plus cytoxan(CTX)on patients with anti-melanoma differentiation-associated gene 5(MDA 5)antibody-positive dermatomyositis(DM)with interstitial lung disease(ILD). Methods The data of 40 patients with MDA 5 positive DM and ILD diagnosed in the People's Hospital of Pu'er City from June 2014 to June 2023 were retrospectively was analyzed.Twenty patients of the treatment group were treated with plasmapheresis combined with PDN 1mg / kg once daily,which was reduced by 10% per week after 4 weeks.The other 20 patients of the control group were treated with PDN 1mg / kg once daily,which was reduced after 4 weeks by 10% per week,and CTX 1g once per month.diffusing capacity of the lungs for carbon monoxide(DLCO),forced expiratory volume in the first second(FEV1),serum ferritin(SF),C-reactive protein(CRP),Krebs Von den Lungen-6(KL-6)and MDA5 negative conversion rate were measured at 3 and 6 months after treatment,respectively. Results At 3 and 6 months of treatment,complete remission rates of DLCO,FEV1,SF,CRP,KL-6,MDA 5 conversion and other indicators were inconsistent.Among them,at 3 months,the complete response rate of the above indicators in the treatment group was successively:95%,85%,90%,90%,90% and 85%.The control group was 15%,20%,20%,15%,and 0%,0%.Statistical analysis showed that the levels of DLCO,FEV1,SF,CRP,KL-6 and MDA 5 significantly varied at 3 months of treatment.Pairwise comparison of LSD found that the DLCO,KL-6 and CRP levels in the treatment group were significantly lower than the control group(P<0.01),the FEV1 level in the treatment group was significantly higher(P<0.01),and the SF level in the treatment group was significantly lower(P<0.05).After 6 month of treatment,the complete response rate of the above indicators in the treatment group were 95%,85%,90%,90%,90% and 85%,and the complete response rate of the above indicators in the control group was 20%,25%,20%,20%,20% and 5%.Statistical analysis showed the levels of DLCO,FEV1,SF,CRP,KL-6 for the amount of MDA 5 and the number of deaths between two groups were significantly different.Further pairwise comparison of LSD showed that the DLCO,KL-6 and CRP levels in the treatment group were significantly lower compared with the control group(P<0.01),the FEV1 level was significantly increased compared with the control group(P<0.01),and the SF treatment group was significantly decreased compared with the control group(P<0.05). Conclusions In the treatment of patients with MDA 5 antibody positive DM with ILD,the treatment of plasmapheresis combined with PDN and CTX can significantly improve the efficacy and reduce the mortality rate.
论著

纤维支气管镜肺泡灌洗吸痰术联合药物治疗ICU重症肺部感染患者疗效以及炎症因子的影响

Effect of bronchofiberoptic alveolar lavage and sputum aspiration combined with medication on ICU patients with severe pulmonary infection and the influence of inflammatory factors

:1146-1151
 
目的 探讨对于重症肺部感染患者采用药物+纤维支气管镜肺泡灌洗吸痰术治疗的效果。方法 选取2021年9月—2023年5月在郑州市第一人民医院ICU中94例肺部感染患者,分为观察组、对照组,对照组进行常规治疗,观察组采用药物+纤维支气管镜肺泡灌洗吸痰术治疗,对比两组患者的疗效、症状的缓解时间、炎性因子、实验室相关指标以及不良反应。结果 治疗后,观察组患者的治疗有效率91.49%高于对照组76.60%(χ2=3.887,P<0.05),观察组患者的发热、肺部湿啰音、咳嗽以及咳痰等症状的缓解时间分别为(3.09±1.25)(4.17±2.24)(3.95±1.53)(4.05±1.77)d,均低于对照组(5.14±2.43)(7.03±3.23)(6.40±2.62)(6.32±1.81)d(t=5.143、4.988、5.536、6.147,P<0.05),观察组的 C 反应性蛋白(C-reactive protein,CRP)、白细胞介素-6(Interleukin-6,IL-6)以及Toll样受体4(Toll-like receptor 4,TLR-4)水平分别为(3.64±0.87)mg/L、(54.59±10.65)ng/mL、(7.94±1.57)%,均低于对照组(7.51±1.43)mg/L、(87.66±11.17)ng/mL、(12.11±2.48)%(t=15.850、14.690、9.740,P<0.05),观察组的气道压力、动脉血二氧化碳分压(partial pressure of carbon dioxide in artery,PaCO2)水平分别为(6.92±3.60)cmH2O、(43.19±6.29)mmHg,低于对照组(8.68±2.98)cmH2O、(55.43±5.95)mmHg,观察组动脉氧分压(Partial arterial oxygen pressure,PaO2)(86.06±5.31)mmHg、血氧饱和度(oxyhemoglobin saturation,SpO2)(98.03±6.63)%高于对照组(68.04±5.19)mmHg、(90.22±5.51)%要高(t=2.582、9.692、16.638、6.221,P<0.05),观察组中的不良反应发生率为2.13%与对照组10.64%比较差异无统计学意义(χ2=2.849,P>0.05)。结论 对处于ICU中的肺部感染患者治疗时,使用药物+纤维支气管镜肺泡灌洗吸痰术能够改善患者症状,降低炎性因子水平。
Objective To investigate the efficacy of medication combined with bronchoscopic alveolar lavage and sputum aspiration in ICU patients with severe pulmonary infection. Methods Ninety-four patients with pulmonary infection in the ICU of Zhengzhou First People's Hospital from September 2021 to May 2023 were selected and divided into observation group and control group.The control group received routine treatment,and the observation group was treated with medication and bronchoscopic alveolar lavage and sputum aspiration.The efficacy,duration of symptom remission,inflammatory factors,laboratory-related indicators and adverse reactions were compared between the two groups. Results After treatment,the effective rate of 91.49% in observation group was significantly higher than 76.60% in control group(χ2=3.887,P<0.05).The relief time of fever,pulmonary rale,cough and sputum in observation group was(3.09±1.25)d,(4.17±2.24)d,(3.95±1.53)d,and(4.05±1.77)d,respectively,which were significantly lower than the control group[(5.14±2.43)d,(7.03±3.23)d,(6.40±2.62)d and(6.32±1.81)d](t=5.143,4.988,5.536,6.147,P<0.05).The levels of CRP,IL-6 and TLR-4 in the observation group were(3.64±0.87)mg/L,(54.59±10.65)ng/mL and(7.94±1.57)%,respectively.They were significantly lower than(7.51±1.43)mg/L,(87.66±11.17)ng/mL and(12.11±2.48)% in the control group(t=15.850,14.690,9.740,P<0.05).The airway pressure and PaCO2 levels of the observation group were(6.92±3.60)cmH2O and(43.19±6.29)mmHg,respectively,which were significantly lower than those of the control group[(8.68±2.98)cmH2O and(55.43±5.95)mmHg].The levels of PaO2[(86.06±5.31)mmHg] and SpO2[(98.03±6.63)%] in the observation group were higher than those in the control group[(68.04±5.19)mmHg and(90.22±5.51)%],and there were statistically significant differences(t=2.582,9.692,16.638,6.221,P<0.05).The adverse reactions of 2.13% in the observation group were lower than 10.64% in the control group,and there was no statistically significant difference(χ2=2.849,P>0.05). Conclusions In ICU patients with severe lung infection,the treatment of drugs combined with alveolar lavage and fiberoptic bronchoscopic aspiration is better,and can significantly improve the symptoms and inflammatory factor levels of patients.
论著

依奇珠单抗治疗中重度斑块型银屑病疗效观察

Observation on the therapeutic effect of Ixekizumab in the treatment of moderate to severe plaque psoriasis

:1129-1133
 
目的 探讨依奇珠单抗对中重度斑块型银屑病的治疗效果。方法 选取厦门大学附属第一医院2022年1月—2023年8月收治的75例中重度斑块型银屑病患者,应用抽签法进行分组,分为试验组(n=35)与对照组(n=40)。对照组采取常规外用药物治疗,试验组采取依奇珠单抗治疗。对比两组临床疗效,治疗前后外周血调节性T细胞(Treg)和辅助性T细胞17(Th17/Treg)细胞水平变化,并对所有患者进行6个月门诊复查随访,对比复发率及不良反应。结果 试验组总有效率88.57%,高于对照组的67.50%(χ2=4.730,P=0.028);治疗后两组患者Treg细胞升高,试验组(5.59±1.24)%高于对照组(4.12±1.13)%,对比差异有统计学意义(t=5.371,P<0.001),Th17细胞、Th17/Treg细胞降低,试验组[(1.06±0.14)%、0.19±0.05]低于对照组[(1.71±0.28)%、0.42±0.14],对比差异有统计学意义(t=12.434、9.212,P<0.001);试验组停药后6个月复发率低于对照组(5.71% vs 27.50%,χ2=6.180,P=0.013);试验组不良反应发生率略高于对照组,组间对比差异无统计学意义(14.29% vs 5.00%,χ2=1.900,P=0.168)。结论 依奇珠单抗治疗中重度斑块型银屑病疗效显著,可调节Th17/Treg平衡,降低停药后复发率,且安全性较高。
Objective To explore the therapeutic effect of Ixekizumab on moderate to severe plaque psoriasis. Methods Seventy-five patients with moderate to severe plaque psoriasis who were admitted to the First Affiliated Hospital of Xiamen University from January 2022 to August 2023 were selected and allocated by lottery into an experimental group(n=35)and a control group(n=40).The control group received routine external medication while the experimental group received Ixekizumab treatment.The clinical efficacy of two groups,changes in Th17/Treg cell values before and after treatment were compared,and a 6-month outpatient follow-up for all patients was conducted to compare recurrence rates and incidence of adverse reactions. Results The total response rate in the experimental group was 88.57%,which was higher than the 67.50% in the control group(χ2=4.730,P=0.028).After treatment,the level of Treg cell in the two groups was significantly higher,and the level of Treg cell experimental in the group was higher than that in the control group[(5.59±1.24)% vs (4.12±1.13)%,t=5.371,P<0.001].After treatment,the level of Th17 and Th17/Treg cell in the two groups were lower,and the level of Th17 cell and Th17/Treg in the experimental group[(1.06±0.14)%,0.19±0.05] were significantly lower than those in the control group[(1.71±0.28)%,0.42±0.14],which was statistically significant(t=12.434、9.212,P<0.001).The relapse rate at 6 months after drug withdrawal in the experimental group was significantly lower than that in the control group(5.71% vs 27.50,χ2=6.180,P=0.013).The incidence of adverse reactions in the experimental group was higher than that in the control group,but with no statistical significance(14.29% vs 5.00%,χ2=1.900,P=0.168). Conclusions Ixekizumab has a significant therapeutic effect on moderate to severe plaque psoriasis.It can regulate the Th17/Treg balance and reduce the recurrence rate after discontinuation,and with high safety.
论著

胆囊结石患者经单孔腹腔镜胆囊切除术治疗的回顾性分析

Retrospective analysis of patients with cholecystolithiasis treated by single-incision laparoscopic cholecystectomy

:1319-1324
 
目的 探究单孔腹腔镜胆囊切除术(LC)治疗胆囊结石(GD)患者的效果。方法 回顾性收集2021年1月—2023年9月郑州大学附属郑州中心医院收治的96例GD患者病例资料,按手术方案不同分两组。以接受单孔LC治疗的48例患者列为A组,以接受三孔LC治疗的48例患者列为B组。对比两组围术期指标、手术前后胃肠激素指标[胃泌素(GAS)、胃动素(MTL)]、肝功能指标[天门冬氨酸转氨酶(AST)、丙氨酸氨基转移酶(ALT)]、疼痛介质指标[前列腺素E2(PGE-2)、5-羟色胺(5-HT)]水平、术后并发症发生率。结果 A组手术用时(71.56±6.29)min更长于B组(62.37±5.85)min,术后排气时间(15.37±2.26)h、住院用时(5.30±1.24)d、切口总长度(1.84±0.27)cm短于B组(17.49±3.55)h、(7.64±1.35)d、(4.13±0.35)cm,术中失血量(41.28±4.36)mL低于B组(58.31±6.52)mL更低(均P<0.001);术后1 d A组GAS(113.34±13.47)pg/mL、MTL(202.78±24.68)pg/mL水平高于B组(102.65±11.08)pg/mL、(164.34±20.76)pg/mL(均P<0.001);术后1d A组AST(31.82±3.62)U/L、ALT(40.36±4.74)U/L水平低于B组(38.78±4.03)U/L、(51.60±5.42)U/L(均P<0.001);术后1 d A组SP(55.84±5.90)ng/L、5-HT(132.17±9.16)ng/mL、PGE-2(25.45±4.27)ng/mL水平低于B组(73.27±7.51)ng/L、(173.54±13.32)ng/mL、(31.71±5.24)ng/mL(均P<0.001);A组并发症发生率2.08%(1/48)低于B组16.67%(8/48)更低。结论 与三孔LC治疗GD患者相比,经单孔LC治疗会略微延长手术用时,但能进一步减少术中失血量,降低术后并发症风险,缩短切口长度及患者康复进程,且对机体胃肠功能、肝功能影响更小,对机体造成疼痛应激更轻微,更符合微创特征。
Objective To explore the effect of single-incision laparoscopic cholecystectomy(LC)in the treatment of patients with gallstone disease(GD).Methods Retrospective data of 96 GD patients in Zhengzhou Central Hospital Affiliated to Zhengzhou University(January 2021—September 2023)were collected and divided into two groups according to different surgical protocols.Forty-eight patients receiving single-incision LC were classified as group A,and 48 patients receiving three-port LC were classified as group B.The perioperative indexes,gastrointestinal hormone indexes[gastrin(GAS),motilin(MTL)],liver function indexes[aspartate aminotransferase(AST),alanine aminotransferase(ALT)],pain mediator indexes[prostaglandin E2(PGE-2),5-hydroxytryptamine(5-HT)] before and after operation,and the incidence of postoperative complications were compared between the two groups.Results The operation time in group A was(71.56±6.29)min,which was longer than that in group B(62.37±5.85)min.In group A,the postoperative exhaust time was(15.37±2.26)h,hospitalization time was(5.30±1.24)d,and the total length of incision was(1.84±0.27)cm,which were shorter than those in group B[(17.49±3.55)h,(7.64±1.35)d,and(4.13±0.35)cm].The intraoperative blood loss was(41.28±4.36)mL,which were lower than(58.31±6.52)mL in group B(all P<0.001).The levels of GAS[(113.34±13.47)pg/mL] and MTL[(202.78±24.68)pg/mL] in group A were higher than those in group B[(102.65±11.08)pg/mL and(164.34±20.76)pg/mL](all P<0.001).The levels of AST[(31.82±3.62)U/L] and ALT[(40.36±4.74)U/L] in group A were lower than those in group B[(38.78±4.03)U/L and(51.60±5.42)U/L](all P<0.001).The levels of SP[(55.84±5.90)ng/L],5-HT[(132.17±9.16)ng/mL],pge-2[(25.45±4.27)ng/mL] in group A were lower than those in group B[(73.27±7.51)ng/L,(173.54±13.32)ng/mL and (31.71±5.24)ng/mL](all P<0.001).The incidence of complications in group A was 2.08%(1/48),which was lower than that in group B[16.67%(8/48)](χ2=4.414,P=0.036).Conclusion sCompared with three-port LC for GD patients,single-incision LC can slightly prolong the operation time,but it can further reduce the intraoperative blood loss,reduce the risk of postoperative complications,shorten the incision length and the rehabilitation process of patients,and has less impact on the gastrointestinal function and liver function,causing less pain stress to the body,which is more in line with the characteristics of minimally invasive.
论著

无痛消化内镜下高频电刀治疗对胃癌前病变的应用效果及复发率的影响

The application effect and recurrence rate of high-frequency electric knife therapy under painless digestive endoscopy on gastric precancerous lesions

:1314-1318
 
目的 探讨无痛消化内镜下高频电刀治疗对胃癌前病变的应用效果及复发率的影响。方法 选取甘肃医学院附属医院2017年1月—2020年1月收治的120例胃癌前病变患者进行回顾性分析,依照其手术治疗方案将其分为两组,各60例。对照组采取常规内镜黏膜下剥离术,观察组患者采取无痛消化内镜下高频电刀剥离治疗。对比两组的切除速度、切除面积、治愈性切除率、完全及整块切除率,对患者进行3年随访,记录其复发情况,并对比两组患者并发症情况。结果 两组的切除面积、治愈性切除率、完全切除率及整块切除率对比差异无统计学意义(P>0.05),观察组切除速度为(27.34±8.58)mm2/min,高于对照组的(15.54±4.52)mm2/min,差异有统计学意义(P<0.05)。两组患者术后3年的总复发率(28.33% vs 30.00%)对比差异无统计学意义(P>0.05)。观察组感染、穿孔等相关并发症发生率为3.33%,低于对照组的15.00%(P<0.05)。结论 无痛消化内镜下高频电刀与常规内镜黏膜下剥离术治疗胃癌前病变相比具有显著疗效。但无痛消化内镜下高频电刀治疗可提升切除速度,降低并发症发生率。
Objective To explore the application effect and recurrence rate of painless endoscopic high-frequency electrocautery on gastric precancerous lesions.Methods A total of 120 patients with precancerous gastric cancer admitted to the Affiliated Hospital of Gansu Medical College from January 2017 to January 2020 were selected for retrospective analysis and divided into two groups according to their surgical treatment plan,with 60 patients in each group.The control group underwent conventional endoscopic submucosal dissection,and the patients in the observation group received painless digestive endoscopic high-frequency electric knife dissection.The resection speed,resection area,curative resection rate,complete and bulk resection rate were compared of the two groups,the patients were followed up for 3 years to record the recurrence rate,and the complications of the two groups of patients were also compared.Results There were no differences in resection area,curative resection rate,complete resection rate and total resection rate between the two groups(P>0.05).The resection speed in the observation group was(27.34±8.58)mm2/min,which was higher than that in the control group(15.54±4.52)mm2/min(P<0.05).There was no difference in the total recurrence rate(28.33% vs 30.00%)at 3 years after surgery between the two groups(P>0.05).The incidence of infection,perforation and other related complications in the observation group was 3.33%,lower than that in the control group(15.00%)(P<0.05).Conclusion sCompared with conventional endoscopic submucosal dissection,high-frequency electric knife under painless digestive endoscopy has significant efficacy in the treatment of gastric precancerous lesions.However,painless endoscopic high-frequency electrosurgical treatment can improve the resection speed and reduce the incidence of complications such as infection,perforation and bleeding.
护理研究

关节镜下治疗慢性踝关节不稳定的护理与康复

Nursing and rehabilitation of arthroscopic treatment of chronic ankle instability

:1500-1505
 
目的 探讨关节镜下外侧韧带增强固定修复术治疗慢性踝关节不稳定的护理和康复方案。方法 回顾性分析2023年1月–2023年8月广州市正骨医院收治的31例采用关节镜下外侧韧带增强固定修复术治疗的慢性踝关节不稳定患者的围术期护理措施和康复指导措施。结果 31例患者均随访无脱落,于术后3、6、12个月返院复查随访,患者手术后患足美国矫形外科足踝协会(AOFAS)踝-后足评分均较前次随访评分提高(均P<0.05)。患者术后3个月Zung焦虑评分和Zung抑郁评分较术前均明显下降(均P<0.05)。31例患者术后无1例发生踝关节不稳定复发、腓肠神经损伤和感染等并发症。结论 关节镜下外侧韧带增强固定修复术的方法治疗慢性踝关节不稳定患者,加强术前术后的护理措施、康复指导,对恢复踝关节稳定性和灵活性有重要作用,有利于提高患者生活质量和满意度。
Objective To investigate the nursing and rehabilitation of chronic ankle instability with reinforcement fixation and repair of lateral ligament under arthroscopy.Methods The perioperative nursing measures and rehabilitation guidance of 31 patients with chronic ankle instability treated with lateral ligament reinforcement fixation under arthroscopy from January 2023 to August 2023 were analyzed retrospectively.Results None of the 31 patients was disassociated during follow-up.The American Orthopaedic Foot and Ankle Society(AOFAS)scores of the patients were significantly higher and higher at 3,6 and 12 months after surgery(all P<0.05).The Zung anxiety score and Zung depression score at 3 months after operation were significantly lower than those before operation(all P<0.05).None of the 31 patients had postoperative complications such as ankle instability recurrence,sural nerve injury,peroneal tendinitis and infection.Conclusions In arthroscopic reinforcement fixation of lateral ligament in the treatment of patients with chronic ankle instability,strengthening the perioperative nursing measures and rehabilitation guidance,plays an important role in restoring the stability and flexibility of the ankle,and is conducive to improving the quality of life and satisfaction of patients.
专家述评

基于MRI的人工智能技术在乳腺癌新辅助治疗疗效评估中的应用与进展

Application and progress of MRI-based artificial intelligence technology in evaluating the response to neoadjuvant therapy for breast cancer

:1381-1388
 
乳腺癌是女性最常见的原发恶性肿瘤之一。目前,通过采用综合治疗手段,包括手术、新辅助治疗、辅助放化疗等多种手段,乳腺癌已成为疗效最佳的实体肿瘤之一。其中,新辅助治疗(NAT)包括新辅助化疗、靶向治疗和内分泌治疗,目的是使肿瘤降期、保乳、保腋窝,并可观察药物敏感性,是当前乳腺癌综合治疗中非常重要的组成部分,其治疗疗效对患者手术方式的选择和预后至关重要。尽管病理学评价在评估NAT疗效方面被公认为金标准,但其局限性在于只能通过有创手段在治疗后进行,无法在治疗前对患者做出准确预测。磁共振成像(MRI)作为一项广泛使用的乳腺成像技术,在评估NAT疗效中扮演着关键角色。近年来,人工智能技术,尤其是影像组学(Radiomics)和深度学习(Deep Learning),在医学影像分析领域取得了显著进展。这些技术能够从医学图像中提取大量肉眼难以识别的特征,揭示病变内部的微观结构和生物学行为,全面反映肿瘤的异质性,这不仅有助于临床医生更准确地区分良、恶性肿瘤,还能对恶性肿瘤的预后进行更为精确的评估。本文系统综述了近年来基于MRI的人工智能技术在乳腺癌新辅助治疗疗效评估中的应用研究,旨在促进人工智能在NAT临床实践中的应用和发展,为乳腺癌NAT治疗策略的优化和个性化医疗的实现提供科学依据。
Breast cancer is one of the most common primary malignant tumors in women.Currently,breast cancer has become one of the most effective solid tumors by using comprehensive treatment methods,including surgery,neoadjuvant therapy,adjuvant radiotherapy and chemotherapy.Among them,neoadjuvant therapy(NAT),including neoadjuvant chemotherapy,targeted therapy and endocrine therapy,is a very important part of the current comprehensive treatment of breast cancer.It aims to reduce the tumor stage,preserve the breast,preserve the armpit,and observe the drug sensitivity.Its therapeutic effect is crucial to the choice of surgical methods and prognosis of patients.Although pathological evaluation is recognized as the gold standard in evaluating the response to NAT,its limitation is that it can only be performed after treatment by invasive means,and cannot accurately predict response before treatment.As a widely used breast imaging technology,magnetic resonance imaging(MRI)plays a key role in evaluating the response to NAT.However,traditional MRI evaluation methods are limited by the individual differences of interobserver and the low repeatability of evaluation results,which affects the accuracy of efficacy evaluation to a certain extent.In recent years,artificial intelligence technology,especially radiomics and deep learning,has made significant progress in the field of medical image analysis.These techniques can extract a large number of features that are difficult to be recognized by the naked eye from medical images,reveal the internal microstructure and biological behavior of the lesion,and fully reflect the heterogeneity of the tumor.This not only helps clinicians to distinguish benign and malignant tumors more accurately,but also makes a more accurate assessment of the prognosis of malignant tumors.This article reviews the application and progress of MRI-based artificial intelligence technology in evaluating the response to neoadjuvant therapy for breast cancer in the past five years,aiming to promote the application and development of artificial intelligence in NAT clinical practice,and provide a scientific basis for the optimization of NAT treatment strategy and the realization of personalized medicine for breast cancer.
临床诊疗

镇肝熄风汤加减在VBI性眩晕患者辅助治疗中的应用

:87-90
 
目的 观察镇肝熄风汤加减在椎-基底动脉供血不足(VBI)性眩晕患者辅助治疗中的应用。方法 选取2019年5月—2021年2月我院收治的124例VBI性眩晕患者,按照随机数字表法1:1配对原则分为观察组(n=62)、对照组(n=62),其中对照组给予长春西汀+天麻素,观察组在对照组基础上辅以镇肝熄风汤加减,对比2组疗效、经颅多普勒检查结果[基底动脉、椎动脉平均血流速度(MV)与血管搏动指数(PI)]、眩晕评估量表(DARS)、眩晕障碍调查表(DHI)评分及血液流变学指标(纤维蛋白原、红细胞积压、全血粘度)。结果 观察组总有效率95.16%(59/62)高于对照组82.26%(51/62)(P<0.05);治疗14 d后观察组椎动脉、基底动脉PI低于对照组,MV高于对照组(P<0.05);治疗14 d后观察组DHI评分、DARS评分低于对照组(P<0.05);治疗14 d后观察组纤维蛋白原、红细胞积压、全血粘度低于对照组(P<0.05)。结论 镇肝熄风汤加减辅助治疗VBI性眩晕患者疗效显著,可有效减轻眩晕症状,调节血液粘度,改善椎-基底动脉血流,促进脑部供血恢复。
临床诊疗

氨溴索静脉用药联合不同通气方式治疗新生儿呼吸窘迫综合征的疗效评价

:76-79
 
目的 研究氨溴索静脉用药联合不同通气方式治疗新生儿呼吸窘迫综合征(NRDS)的临床疗效。方法 选取2019年2月—2021年1月我院收治的98例NRDS患儿,根据治疗方案不同分为对照组(49例)和观察组(49例)。2组均给予常规治疗,对照组采用氨溴索静脉用药、常规机械通气治疗,观察组采用氨溴索静脉用药、高频振荡通气(HFOV)治疗。比较2组临床疗效、胸部X线评分、新生儿评分(Apgar评分)、不同时间点(治疗前、治疗后2 h、治疗后12 h)动脉血气指标[氧合指数(OI)、动脉氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)]、呼吸力学指标[呼吸指数(RI)、呼吸道阻力(R)、肺动态顺应性(Crs)]、并发症发生率、死亡率。结果 2组治疗后总有效率比较,观察组93.88%高于对照组77.55%(P<0.05);治疗后,观察组胸部X线评分、Apgar评分均高于对照组(P<0.05);治疗后2 h、治疗后12 h时观察组OI、PaCO2均低于对照组,PaO2高于对照组(P<0.05);治疗后,观察组RI、AR水平低于对照组,Crs水平高于对照组(P<0.05);观察组死亡率2.04%低于对照组14.29%(P<0.05)。结论 氨溴索静脉用药联合HFOV治疗NRDS的临床疗效显著,可有效促进患儿呼吸功能、动脉血气改善,降低新生儿死亡率。
论著

悬吊运动疗法配合推拿治疗神经根型颈椎病临床价值

Clinical value of sling exercise therapy combined with massage in the treatment of cervical spondylotic radiculopathy

:64-67
 
目的 探究对神经根型颈椎病(CSR)患者开展悬吊运动疗法+推拿的临床价值。方法 选择2020年1月—2021年7月100例神经根型颈椎病患者,参考“数字双盲法”,分为对照组和观察组(均n=50);对照组患者为推拿治疗,观察组基于对照组基础+悬吊运动疗法;对比治疗结果。结果 观察组临床总有效率94.00%较对照组80.00%高(P<0.05)。2组治疗后VAS疼痛评分较治疗前均下降,且观察组较对照组更低(P<0.05)。治疗前120°/s的等速度运动状态下2组峰力距(PT)、平均功率(AP)、屈肌峰力距/伸肌峰力距(F/E)比较(P>0.05),经治疗后2组均显著改善,且观察组PT、AP、F/E指标较对照组均更优(P<0.05)。2组治疗后颈椎功能障碍指数(NDI)评分、颈椎病临床评价量表(CASCS)评分较同组治疗前均改善,且观察组较对照组NDI评分更低,CASCS评分更高。结论 针对CSR患者开展悬吊运动疗法+推拿治疗,有利于调节患者颈部肌群协调能力,减轻疼痛感,改善临床症状,促进颈椎功能恢复,实现理想的治疗效果。
Objective To explore the clinical value of sling exercise therapy (SET) and massage in patients with cervical spondylotic radiculopathy (CSR). Methods From January 2020 to July 2021, 100 patients with CSR were selected and divided into control group and observation group (both n=50). The patients in the control group were treated with massage, and the observation group was treated with massage+SET, the treatment results were compared. Results The total clinical effective rate of 94.00% in the observation group was significantly higher than 80.00% in the control group (P<0.05). The VAS pain scores of the two groups after treatment were lower than those before treatment, and the VAS pain score of the observation group was lower than that of the control group (P<0.05). The peak torque (PT), average power (AP) and flexor peak force distance/extensor peak force distance (F/E) of the two groups were significantly improved after treatment, and the PT, AP and F/E indexes of the observation group were better than those of the control group (P<0.05). After treatment, the neck disability index (NDI) score and clinical assessment scale of cervical spondylosis (CASCS) score of the two groups were significantly improved compared with those before treatment, and the NDI score of the observation group was lower and the CASCS score was higher in the observation group. Conclusions SET+massage therapy for patients with CSR is helpful to adjust the coordination ability of cervical muscle group, reduce pain, improve clinical symptoms, promote the recovery of cervical function and achieve ideal therapeutic effect.
出版者信息








《广州医药》公众号